APP and Alzheimer disease: In particular, the APOEε3-R136S mutation enhanced the microglial response to amyloid plaques and reduced Aβ-induced tau seeding and spreading in human APOEε3-R136S knock-in APP/PS1 mice injected with tau fibrils from human AD brain extracts (Chen et al., 2024).